Considering that B2M is primarily expressed by the stroma of the ESCC tissue, our results further strengthen our hypothesis that in ESCC, MSCs-derived B2M promotes tumor-initiation and invasion via enhancing EMT, resulting in an adverse prognosis for the patients. The gene discussed is B2M; the disease is neoplasm.